A CASE OF IgA-ASSOCIATED MEMBRANOUS NEPHROPATHY WITH RECURRENT RELAPSES AND SUPERIMPOSED DIABETIC NEPHROPATHY: CLINICAL COURSE, PATHOLOGY, AND RESPONSE TO IMMUNOSUPPRESSION.

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1288/11944fdb1358a1bf199313bcc1c5040b.pdf
A CASE OF IgA-ASSOCIATED MEMBRANOUS NEPHROPATHY WITH RECURRENT RELAPSES AND SUPERIMPOSED DIABETIC NEPHROPATHY: CLINICAL COURSE, PATHOLOGY, AND RESPONSE TO IMMUNOSUPPRESSION.

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Yuna
Onozawa
Yuna Onozawa yunarun4542@gmail.com Tokai University School of Medicine Division of Nephrology, Endocrinology, and Metabolism Isehara Japan *
Masahiro Koizumi koiz0907@gmail.com Tokai University School of Medicine Division of Nephrology, Endocrinology, and Metabolism Isehara Japan -
Takahiro Tsuji tsuji.takahiro@gmail.com Sapporo City General Hospital Department of Pathology Sapporo Japan -
Mizuko Tanaka mizuko@fmu.ac.jp Jusendo General Hospital Department of Pathology Koriyama Japan -
Takehiko Wada takewada@gmail.com Toranomon Hospital Nephrology Center Tokyo Japan -
Hirotaka Komaba hirotaka.komaba@gmail.com Tokai University School of Medicine Division of Nephrology, Endocrinology, and Metabolism Isehara Japan -
Akira Shimizu ashimizu@nms.ac.jp Nippon Medical School Department of Analytic Human Pathology Tokyo Japan -